← Back to Search

Behavioral Intervention

Intervention arm for Anxiety

N/A

Waitlist Available

Led By Daniel V Vigo, MD, Lic. Psych, DrPH

Research Sponsored by University of British Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the phq-9 will be administered to both the intervention and control group at baseline and 30 days.

Awards & highlights

Study Summary

This trial will test if a mobile app can help university students with their mental health and substance use.

Eligible Conditions

Anxiety
Depression
Alcoholism
Substance Abuse

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the phq-9 will be administered to both the intervention and control group at baseline and 30 days.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the phq-9 will be administered to both the intervention and control group at baseline and 30 days.

This trial's timeline: 3 weeks for screening, Varies for treatment, and the phq-9 will be administered to both the intervention and control group at baseline and 30 days. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Alcohol consumption risk from Baseline to Follow-up at 30 days

Mental Depression

Change in General anxiety symptomology from Baseline to Follow-up at 30 days

Secondary outcome measures

Alcohol Use Disorder

Bulimia

Frequency of cannabis consumption

+7 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention armExperimental Treatment1 Intervention

Participants randomized into the intervention arm will be given immediate access to a fully functional version of the Minder app that includes baseline, interim and follow-up surveys and access to all app components and e-coaching.

Group II: Control armActive Control1 Intervention

Participants randomized into the control arm will be given access to a restricted version of the app that only includes access to a generic study introduction video and baseline and follow up survey assessments delivered via the app.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Minder

2022

N/A

~1490

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor

1,415 Previous Clinical Trials

2,465,527 Total Patients Enrolled

8 Trials studying Anxiety

1,230 Patients Enrolled for Anxiety

Daniel V Vigo, MD, Lic. Psych, DrPHPrincipal InvestigatorUniversity of British Columbia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total number of participants in this clinical study?

"Correct. Per clinicaltrials.gov, this medical study is actively seeking participants since its posting on September 28th 2022 and the most recent update was made on November 3rd 2022. It requires 1496 patients to be recruited from a single site."

Answered by AI

What outcome is this exploration hoping to produce?

"The primary outcome evaluated during this trial, measured over the span of a month, is Depression symptomology as assessed using the GAD-7. Secondary outcomes consider fluctuations in Self-reported frequency of non-medical stimulant use, cannabis consumption and opioid use from baseline to follow up."

Answered by AI

Is it possible to enroll in this clinical experiment at the moment?

"This clinical trial is still accepting participants. It was first posted on September 28th 2022 and has been updated recently, with the most recent edit occurring November 3rd that same year."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

An Online Intervention Addressing Mental Health and Substance Use in University Students

Daniel Vigo 2022. "An Online Intervention Addressing Mental Health and Substance Use in University Students". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05606601.